This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010;37(3):341-2.

Unintended consequences: avoiding restenosis and stent thrombosis

PMID: 20548818
PMCID: PMC2879204

Editorial

Unintended consequences: avoiding restenosis and stent thrombosis

James M Wilson. Tex Heart Inst J. 2010.

. 2010;37(3):341-2.

Author

PMID: 20548818
PMCID: PMC2879204

No abstract available

PubMed Disclaimer

Comment on

Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
Al-Dehneh A, Virk H, Alkhouri Y, Hamdan A, Bikkina M. Al-Dehneh A, et al. Tex Heart Inst J. 2010;37(3):343-6. Tex Heart Inst J. 2010. PMID: 20548819 Free PMC article. Review.

Similar articles

The excel stent: a good DES, but can we really stop clopidogrel after 6 months?
Margolis JR. Margolis JR. JACC Cardiovasc Interv. 2009 Apr;2(4):310-1. doi: 10.1016/j.jcin.2009.01.005. JACC Cardiovasc Interv. 2009. PMID: 19463442 No abstract available.
Drug-eluting stents: safe but not sufficient.
Vogel RA. Vogel RA. JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002. JACC Cardiovasc Interv. 2009. PMID: 19539254 No abstract available.
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y, Jing Q, Xu B, Yang L, Liu H, Shang X, Jiang T, Li Z, Zhang H, Li H, Qiu J, Liu Y, Li Y, Chen X, Gao R; CREATE (Multi-Center Registry of Excel Biodegradable Polymer Drug-Eluting Stents) Investigators. Han Y, et al. JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013. JACC Cardiovasc Interv. 2009. PMID: 19463441 Clinical Trial.
Drug-eluting stent thrombosis.
Stähli BE, Camici GG, Tanner FC. Stähli BE, et al. Ther Adv Cardiovasc Dis. 2009 Feb;3(1):45-52. doi: 10.1177/1753944708096280. Epub 2008 Sep 18. Ther Adv Cardiovasc Dis. 2009. PMID: 19124388 Review.
Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.
Al-Dehneh A, Virk H, Alkhouri Y, Hamdan A, Bikkina M. Al-Dehneh A, et al. Tex Heart Inst J. 2010;37(3):343-6. Tex Heart Inst J. 2010. PMID: 20548819 Free PMC article. Review.

See all similar articles

References

1. Shen ZJ, Garcia-Garcia HM, Garg S, Onuma Y, Schenkeveld L, van Domburg RT, et al. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry. Catheter Cardiovasc Interv 2009;74(7):979–86. - PubMed
1. Al-Dehneh A, Virk H, Alkhouri Y, Hamdan A, Bikkina M. Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review. Tex Heart Inst J 2010; 37(3):343–6. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information